Exposure to low dose ionising radiation: Molecular and clinical consequences

Cancer Letters

Volumn 338, Issue 2, 2013, Pages 209-218

  Martin, Lynn M ^a   Marples, Brian ^b   Lynch, Thomas H ^a   Hollywood, Donal ^a   Marignol, Laure ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

Cell cycle arrest; DNA damage; Hypersensitivity; Ionising radiation; Low dose

Indexed keywords

ATM PROTEIN; BRCA2 PROTEIN; CASPASE 2; HISTONE H2AX; PROTEIN P52; RAD51 PROTEIN;

CANCER CELL; CANCER RADIOTHERAPY; CELL CYCLE ARREST; CELL KILLING; COMPUTER ASSISTED RADIOTHERAPY; DNA DAMAGE; DNA REPAIR; GLIOBLASTOMA; HUMAN; HYPER RADIOSENSITIVITY; INTENSITY MODULATED RADIATION THERAPY; IONIZING RADIATION; LOW ENERGY RADIATION; MAMMAL CELL; MISMATCH REPAIR; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION EXPOSURE; RADIATION RESPONSE; RADIATION SAFETY; RADIOSENSITIVITY; SHORT SURVEY; VOLUMETRIC MODULATED ARC THERAPY;

MAMMALIA;

CELL CYCLE ARREST; DNA DAMAGE; HYPERSENSITIVITY; IONISING RADIATION; LOW DOSE;

CELL CYCLE; CELL SURVIVAL; DNA DAMAGE; DNA REPAIR; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; NEOPLASMS; RADIATION TOLERANCE; RADIATION, IONIZING; RADIOTHERAPY;

EID: 84881660442     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.05.021     Document Type: Review

References (118)

1. Balducci M., Chiesa S., Diletto B., D'Agostino G.R., Mangiola A., Manfrida S., Mantini G., Albanese A., Fiorentino A., Frascino V., De Bari B., Micciche F., De Rose F., Morganti A.G., Anile C., Valentini V. Low-dose fractionated radiotherapy and concomitant chemotherapy in glioblastoma multiforme with poor prognosis: a feasibility study. Neuro Oncol. 2012, 14:79-86.
2. Bartkowiak D., Hogner S., Nothdurft W., Rottinger E.M. Cell cycle and growth response of CHO cells to X-irradiation: threshold-free repair at low doses. Int. J. Radiat. Oncol. Biol. Phys. 2001, 50:221-227.
3. Bassing C.H., Chua K.F., Sekiguchi J., Suh H., Whitlow S.R., Fleming J.C., Monroe B.C., Ciccone D.N., Yan C., Vlasakova K., Livingston D.M., Ferguson D.O., Scully R., Alt F.W. Increased ionizing radiation sensitivity and genomic instability in the absence of histone H2AX. Proc. Natl. Acad. Sci. USA 2002, 99:8173-8178.
4. Bauman G., Rumble R.B., Chen J., Loblaw A., Warde P. I.I.E.P. Members of the Intensity-modulated radiotherapy in the treatment of prostate cancer. Clin. Oncol. (R. Coll. Radiol.) 2012, 24:461-473.
5. Beauchesne P.D., Bertrand S., Branche R., Linke S.P., Revel R., Dore J.F., Pedeux R.M. Human malignant glioma cell lines are sensitive to low radiation doses. Int. J. Cancer 2003, 105:33-40.
6. Branzei D., Foiani M. Regulation of DNA repair throughout the cell cycle. Nat. Rev. Mol. Cell Biol. 2008, 9:297-308.
7. Brown K.D., Rathi A., Kamath R., Beardsley D.I., Zhan Q., Mannino J.L., Baskaran R. The mismatch repair system is required for S-phase checkpoint activation. Nat. Genet. 2003, 33:80-84.
8. Cejka P., Stojic L., Marra G., Jiricny J. Is mismatch repair really required for ionizing radiation-induced DNA damage signaling?. Nat. Genet. 2004, 36:432-433. (author reply 434).
9. Chalmers A., Johnston P., Woodcock M., Joiner M., Marples B. PARP-1, PARP-2, and the cellular response to low doses of ionizing radiation. Int. J. Radiat. Oncol. Biol. Phys. 2004, 58:410-419.
10. Chandna S., Dwarakanath B.S., Khaitan D., Mathew T.L., Jain V. Low-dose radiation hypersensitivity in human tumor cell lines: effects of cell-cell contact and nutritional deprivation. Radiat. Res. 2002, 157:516-525.
11. Collis S.J., Schwaninger J.M., Ntambi A.J., Keller T.W., Nelson W.G., Dillehay L.E., Deweese T.L. Evasion of early cellular response mechanisms following low level radiation-induced DNA damage. J. Biol. Chem. 2004, 279:49624-49632.
12. Dai X., Tao D., Wu H., Cheng J. Low dose hyper-radiosensitivity in human lung cancer cell line A549 and its possible mechanisms. J. Huazhong Univ. Sci. Technol. Med. Sci. 2009, 29:101-106.
13. Deorukhkar A., Krishnan S. Targeting inflammatory pathways for tumor radiosensitization. Biochem. Pharmacol. 2010, 80:1904-1914.
14. Dey S., Spring P.M., Arnold S., Valentino J., Chendil D., Regine W.F., Mohiuddin M., Ahmed M.M. Low-dose fractionated radiation potentiates the effects of Paclitaxel in wild-type and mutant p53 head and neck tumor cell lines. Clin. Cancer Res. 2003, 9:1557-1565.
15. Dionet C., Tchirkov A., Alard J.P., Arnold J., Dhermain J., Rapp M., Bodez V., Tamain J.C., Monbel I., Malet P., Kwiatkowski F., Donnarieix D., Veyre A., Verrelle P. Effects of low-dose neutrons applied at reduced dose rate on human melanoma cells. Radiat. Res. 2000, 154:406-411.
16. Edin N.J., Olsen D.R., Sandvik J.A., Malinen E., Pettersen E.O. Low dose hyper-radiosensitivity is eliminated during exposure to cycling hypoxia but returns after reoxygenation. Int. J. Radiat. Biol. 2012, 88:311-319.
17. Enns L., Bogen K.T., Wizniak J., Murtha A.D., Weinfeld M. Low-dose radiation hypersensitivity is associated with p53-dependent apoptosis. Mol. Cancer Res. 2004, 2:557-566.
18. Fernet M., Megnin-Chanet F., Hall J., Favaudon V. Control of the G2/M checkpoints after exposure to low doses of ionising radiation: implications for hyper-radiosensitivity. DNA Repair (Amst.) 2009, 9:48-57.
19. Franchitto A., Pichierri P., Piergentili R., Crescenzi M., Bignami M., Palitti F. The mammalian mismatch repair protein MSH2 is required for correct MRE11 and RAD51 relocalization and for efficient cell cycle arrest induced by ionizing radiation in G2 phase. Oncogene 2003, 22:2110-2120.
20. Garcia L.M., Leblanc J., Wilkins D., Raaphorst G.P. Fitting the linear-quadratic model to detailed data sets for different dose ranges. Phys. Med. Biol. 2006, 51:2813-2823.
21. Gregoire V., Jeraj R., Lee J.A., O'Sullivan B. Radiotherapy for head and neck tumours in 2012 and beyond: conformal, tailored, and adaptive?. Lancet Oncol. 2012, 13:e292-e300.
22. Guirado D., Aranda M., Ortiz M., Mesa J.A., Zamora L.I., Amaya E., Villalobos M., Lallena A.M. Low-dose radiation hyper-radiosensitivity in multicellular tumour spheroids. Br. J. Radiol. 2012, 85:1398-1406.
23. Gupta S., Koru-Sengul T., Arnold S.M., Devi G.R., Mohiuddin M., Ahmed M.M. Low-dose fractionated radiation potentiates the effects of cisplatin independent of the hyper-radiation sensitivity in human lung cancer cells. Mol. Cancer Ther. 2011, 10:292-302.
24. Hall E.J. Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int. J. Radiat. Oncol. Biol. Phys. 2006, 65:1-7.
25. Hall E.J. Is there a place for quantitative risk assessment?. J. Radiol. Protect. 2009, 29:A171-A184.
26. Hall E.J., Wuu C.S. Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int. J. Radiat. Oncol. Biol. Phys. 2003, 56:83-88.
27. Hamilton C.S., Denham J.W., O'Brien M., Ostwald P., Kron T., Wright S., Drr W. Underprediction of human skin erythema at low doses per fraction by the linear quadratic model. Radiother. Oncol. 1996, 40:23-30.
28. Harney J., Shah N., Short S., Daley F., Groom N., Wilson G.D., Joiner M.C., Saunders M.I. The evaluation of low dose hyper-radiosensitivity in normal human skin. Radiother. Oncol. 2004, 70:319-329.
29. Harney J., Short S.C., Shah N., Joiner M., Saunders M.I. Low dose hyper-radiosensitivity in metastatic tumors. Int. J. Radiat. Oncol. Biol. Phys. 2004, 59:1190-1195.
30. Harney J., Short S.C., Shah N., Joiner M., Saunders M.I. Low dose hyper-radiosensitivity in metastatic tumors. Int. J. Radiat. Oncol. Biol. Phys. 2004, 59:1190-1195.
31. Hartwell L.H., Weinert T.A. Checkpoints: controls that ensure the order of cell cycle events. Science 1989, 246:629-634.
32. Hermann R.M., Wolff H.A., Jarry H., Thelen P., Gruendker C., Rave-Fraenk M., Schmidberger H., Christiansen H. In vitro studies on the modification of low-dose hyper-radiosensitivity in prostate cancer cells by incubation with genistein and estradiol. Radiat. Oncol. 2008, 3:19.
33. Honore H.B., Bentzen S.M. A modelling study of the potential influence of low dose hypersensitivity on radiation treatment planning. Radiother. Oncol. 2006, 79:115-121.
34. Houtgraaf J.H., Versmissen J., van der Giessen W.J. A concise review of DNA damage checkpoints and repair in mammalian cells. Cardiovas. Revasculariz. Med.: Mol. Intervent. 2006, 7:165-172.
35. Houtgraaf J.H., Versmissen J., van der Giessen W.J. A concise review of DNA damage checkpoints and repair in mammalian cells. Cardiovas. Revasculariz. Med.: Mol. Intervent. 2006, 7:165-172.
36. Joiner M.C., Denekamp J. The effect of small radiation doses on mouse skin. Br. J. Cancer Suppl. 1986, 7:63-66.
37. Joiner M.C., Denekamp J., Maughan R.L. The use of 'top-up' experiments to investigate the effect of very small doses per fraction in mouse skin. Int. J. Radiat. Biol. Relat. Stud. Phys., Chem., Med. 1986, 49:565-580.
38. Joiner M.C., Marples B., Lambin P., Short S.C., Turesson I. Low-dose hypersensitivity: current status and possible mechanisms. Int. J. Radiat. Oncol. Biol. Phys. 2001, 49:379-389.
39. Joiner M.C., Marples B., Lambin P., Short S.C., Turesson I. Low-dose hypersensitivity: current status and possible mechanisms. Int. J. Radiat. Oncol. Biol. Phys. 2001, 49:379-389.
40. Kass E.M., Jasin M. Collaboration and competition between DNA double-strand break repair pathways. FEBS Lett. 2010, 584:3703-3708.
41. Klein H.L. The consequences of Rad51 overexpression for normal and tumor cells. DNA Repair (Amst.) 2008, 7:686-693.
42. Krause M., Wohlfarth J., Georgi B., Pimentel N., Dorner D., Zips D., Eicheler W., Hessel F., Short S.C., Joiner M.C., Baumann M. Low-dose hyperradiosensitivity of human glioblastoma cell lines in vitro does not translate into improved outcome of ultrafractionated radiotherapy in vivo. Int. J. Radiat. Biol. 2005, 81:751-758.
43. Krueger S.A., Collis S.J., Joiner M.C., Wilson G.D., Marples B. Transition in survival from low-dose hyper-radiosensitivity to increased radioresistance is independent of activation of ATM Ser1981 activity. Int. J. Radiat. Oncol. Biol. Phys. 2007, 69:1262-1271.
44. Krueger S.A., Wilson G.D., Piasentin E., Joiner M.C., Marples B. The effects of G2-phase enrichment and checkpoint abrogation on low-dose hyper-radiosensitivity. Int. J. Radiat. Oncol. Biol. Phys. 2010, 77:1509-1517.
45. Kry S.F., Salehpour M., Followill D.S., Stovall M., Kuban D.A., White R.A., Rosen I.I. The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 2005, 62:1195-1203.
46. Lambin P., Coco-Martin J., Legal J.D., Begg A.C., Parmentier C., Joiner M.C., Malaise E.P. Intrinsic radiosensitivity and chromosome aberration analysis using fluorescence in situ hybridization in cells of two human tumor cell lines. Radiat. Res. 1994, 138:S40-S43.
47. Lambin P., Fertil B., Malaise E.P., Joiner M.C. Multiphasic survival curves for cells of human tumor cell lines: induced repair or hypersensitive subpopulation?. Radiat. Res. 1994, 138:S32-S36.
48. Lambin P., Malaise E.P., Joiner M.C. The effect of very low radiation doses on the human bladder carcinoma cell line RT112. Radiother. Oncol. 1994, 32:63-72.
49. Lambin P., Malaise E.P., Joiner M.C. Might intrinsic radioresistance of human tumour cells be induced by radiation?. Int. J. Radiat. Biol. 1996, 69:279-290.
50. Lambin P., Marples B., Fertil B., Malaise E.P., Joiner M.C. Hypersensitivity of a human tumour cell line to very low radiation doses. Int. J. Radiat. Biol. 1993, 63:639-650.
51. Leonard B.E. Thresholds and transitions for activation of cellular radioprotective mechanisms - correlations between HRS/IRR and the 'inverse' dose-rate effect. Int. J. Radiat. Biol. 2007, 83:479-489.
52. Lin P.S., Wu A. Not all 2 Gray radiation prescriptions are equivalent: cytotoxic effect depends on delivery sequences of partial fractionated doses. Int. J. Radiat. Oncol. Biol. Phys. 2005, 63:536-544.
53. Little M.P. Do non-targeted effects increase or decrease low dose risk in relation to the linear-non-threshold (LNT) model?. Mutat. Res. 2010, 687:17-27.
54. Lodermann B., Wunderlich R., Frey S., Schorn C., Stangl S., Rodel F., Keilholz L., Fietkau R., Gaipl U.S., Frey B. Low dose ionising radiation leads to a NF-kappaB dependent decreased secretion of active IL-1beta by activated macrophages with a discontinuous dose-dependency. Int. J. Radiat. Biol. 2012, 88:727-734.
55. Marples B. Is low-dose hyper-radiosensitivity a measure of G2-phase cell radiosensitivity?. Cancer Metast. Rev. 2004, 23:197-207.
56. Marples B., Adomat H., Koch C.J., Skov K.A. Response of V79 cells to low doses of X-rays and negative pi-mesons: clonogenic survival and DNA strand breaks. Int. J. Radiat. Biol. 1996, 70:429-436.
57. Marples B., Cann N.E., Mitchell C.R., Johnston P.J., Joiner M.C. Evidence for the involvement of DNA-dependent protein kinase in the phenomena of low dose hyper-radiosensitivity and increased radioresistance. Int. J. Radiat. Biol. 2002, 78:1139-1147.
58. Marples B., Collis S.J. Low-dose hyper-radiosensitivity: past, present, and future. Int. J. Radiat. Oncol. Biol. Phys. 2008, 70:1310-1318.
59. Marples B., Joiner M.C. The response of Chinese hamster V79 cells to low radiation doses: evidence of enhanced sensitivity of the whole cell population. Radiat. Res. 1993, 133:41-51.
60. Marples B., Joiner M.C. The elimination of low-dose hypersensitivity in Chinese hamster V79-379A cells by pretreatment with X rays or hydrogen peroxide. Radiat. Res. 1995, 141:160-169.
61. Marples B., Joiner M.C. The elimination of low-dose hypersensitivity in Chinese hamster V79-379A cells by pretreatment with X rays or hydrogen peroxide. Radiat. Res. 1995, 141:160-169.
62. Marples B., Lambin P., Skov K.A., Joiner M.C. Low dose hyper-radiosensitivity and increased radioresistance in mammalian cells. Int. J. Radiat. Biol. 1997, 71:721-735.
63. Marples B., Skov K.A. Small doses of high-linear energy transfer radiation increase the radioresistance of Chinese hamster V79 cells to subsequent X irradiation. Radiat. Res. 1996, 146:382-387.
64. Marples B., Wouters B.G., Joiner M.C. An association between the radiation-induced arrest of G2-phase cells and low-dose hyper-radiosensitivity: a plausible underlying mechanism?. Radiat. Res. 2003, 160:38-45.
65. Martin L., Marples B., Coffey M., Lawler M., Hollywood D., Marignol L. Recognition of O6MeG Lesions by MGMT and mismatch repair proficiency may be a prerequisite for low-dose radiation hypersensitivity. Radiat. Res. 2009, 172:405-413.
66. Martin L.M., Marples B., Coffey M., Lawler M., Lynch T.H., Hollywood D., Marignol L. DNA mismatch repair and the DNA damage response to ionizing radiation: making sense of apparently conflicting data. Cancer Treat. Rev. 2010.
67. Martin L.M., Marples B., Davies A.M., Atzberger A., Edwards C., Lynch T.H., Hollywood D., Marignol L. DNA mismatch repair protein MSH2 dictates cellular survival in response to low dose radiation in endometrial carcinoma cells. Cancer Lett. 2013.
68. McKay M., Peters L. Genetic determinants of radiation response. Report on a symposium held at Peter MacCallum Cancer Institute, Melbourne, Australia, 8 August 1996. Int. J. Radiat. Biol. 1997, 71:225-229.
69. Mothersill C., Seymour C.B., Joiner M.C. Relationship between radiation-induced low-dose hypersensitivity and the bystander effect. Radiat. Res. 2002, 157:526-532.
70. Nardone L., Valentini V., Marino L., De Santis M.C., Terribile D., Franceschini G., Balducci M., Mantini G., Mattiucci G., Mule A., Belli P., Masetti R. A feasibility study of neo-adjuvant low-dose fractionated radiotherapy with two different concurrent anthracycline-docetaxel schedules in stage IIA/B-IIIA breast cancer. Tumori 2012, 98:79-85.
71. Norman A., Kagan A.R., Chan S.L. The importance of genetics for the optimization of radiation therapy, A hypothesis. Am. J. Clin. Oncol. 1988, 11:84-88.
72. Otto K. Volumetric modulated arc therapy: IMRT in a single gantry arc. Med. Phys. 2008, 35:310-317.
73. Preston D.L., Ron E., Tokuoka S., Funamoto S., Nishi N., Soda M., Mabuchi K., Kodama K. Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat. Res. 2007, 168:1-64.
74. Redpath J.L., Short S.C., Woodcock M., Johnston P.J. Low-dose reduction in transformation frequency compared to unirradiated controls: the role of hyper-radiosensitivity to cell death. Radiat. Res. 2003, 159:433-436.
75. Rodel F., Frey B., Gaipl U., Keilholz L., Fournier C., Manda K., Schollnberger H., Hildebrandt G., Rodel C. Modulation of inflammatory immune reactions by low-dose ionizing radiation: molecular mechanisms and clinical application. Curr. Med. Chem. 2012, 19:1741-1750.
76. Rodel F., Frey B., Manda K., Hildebrandt G., Hehlgans S., Keilholz L., Seegenschmiedt M.H., Gaipl U.S., Rodel C. Immunomodulatory properties and molecular effects in inflammatory diseases of low-dose X-irradiation. Front. Oncol. 2012, 2:120.
77. Ruben J.D., Davis S., Evans C., Jones P., Gagliardi F., Haynes M., Hunter A. The effect of intensity-modulated radiotherapy on radiation-induced second malignancies. Int. J. Radiat. Oncol. Biol. Phys. 2008, 70:1530-1536.
78. Ryan L.A., Seymour C.B., Joiner M.C., Mothersill C.E. Radiation-induced adaptive response is not seen in cell lines showing a bystander effect but is seen in lines showing HRS/IRR response. Int. J. Radiat. Biol. 2009, 85:87-95.
79. Schettino G., Folkard M., Prise K.M., Vojnovic B., Bowey A.G., Michael B.D. Low-dose hypersensitivity in Chinese hamster V79 cells targeted with counted protons using a charged-particle microbeam. Radiat. Res. 2001, 156:526-534.
80. Schild D., Wiese C. Overexpression of RAD51 suppresses recombination defects: a possible mechanism to reverse genomic instability. Nucleic Acids Res. 2009.
81. Short S., Mayes C., Woodcock M., Johns H., Joiner M.C. Low dose hypersensitivity in the T98G human glioblastoma cell line. Int. J. Radiat. Biol. 1999, 75:847-855.
82. Short S.C., Bourne S., Martindale C., Woodcock M., Jackson S.P. DNA damage responses at low radiation doses. Radiat. Res. 2005, 164:292-302.
83. Short S.C., Bourne S., Martindale C., Woodcock M., Jackson S.P. DNA damage responses at low radiation doses. Radiat. Res. 2005, 164:292-302.
84. Short S.C., Kelly J., Mayes C.R., Woodcock M., Joiner M.C. Low-dose hypersensitivity after fractionated low-dose irradiation in vitro. Int. J. Radiat. Biol. 2001, 77:655-664.
85. Short S.C., Mitchell S.A., Boulton P., Woodcock M., Joiner M.C. The response of human glioma cell lines to low-dose radiation exposure. Int. J. Radiat. Biol. 1999, 75:1341-1348.
86. Short S.C., Woodcock M., Marples B., Joiner M.C. Effects of cell cycle phase on low-dose hyper-radiosensitivity. Int. J. Radiat. Biol. 2003, 79:99-105.
87. Simonsson M., Qvarnstrom F., Nyman J., Johansson K.A., Garmo H., Turesson I. Low-dose hypersensitive gammaH2AX response and infrequent apoptosis in epidermis from radiotherapy patients. Radiother. Oncol. 2008, 88:388-397.
88. Simonsson M., Qvarnstrom F., Nyman J., Johansson K.A., Garmo H., Turesson I. Low-dose hypersensitive gammaH2AX response and infrequent apoptosis in epidermis from radiotherapy patients. Radiother. Oncol. 2008, 88:388-397.
89. Singh B., Arrand J.E., Joiner M.C. Hypersensitive response of normal human lung epithelial cells at low radiation doses. Int. J. Radiat. Biol. 1994, 65:457-464.
90. Skov K., Marples B., Matthews J.B., Joiner M.C., Zhou H. A preliminary investigation into the extent of increased radioresistance or hyper-radiosensitivity in cells of hamster cell lines known to be deficient in DNA repair. Radiat. Res. 1994, 138:S126-S129.
91. Skov K.A., MacPhail H.S., Marples B. The effect of radiosensitizers on the survival response of hypoxic mammalian cells: the low X-ray dose region, hypersensitivity and induced radioresistance. Radiat. Res. 1994, 138:S113-S116.
92. Slonina D., Biesaga B., Urbanski K., Kojs Z. Low-dose radiation response of primary keratinocytes and fibroblasts from patients with cervix cancer. Radiat. Res. 2007, 167:251-259.
93. Slonina D., Biesaga B., Urbanski K., Kojs Z. The response of primary keratinocytes and fibroblasts from cancer patients to multiple low-dose irradiations. Radiat. Res. 2007, 168:631-636.
94. Slonina D., Biesaga B., Urbanski K., Kojs Z. Comparison of chromosomal radiosensitivity of normal cells with and without HRS-like response and normal tissue reactions in patients with cervix cancer. Int. J. Radiat. Biol. 2008, 84:421-428.
95. Slonina D., Biesaga B., Urbanski K., Kojs Z., Waligorski M. Evidence of low-dose hyper-radiosensitivity in normal cells of cervix cancer patients?. Radiat. Prot. Dosim. 2006, 122:282-284.
96. Slonina D., Biesaga B., Urbanski K., Kojs Z., Waligorski M. Evidence of low-dose hyper-radiosensitivity in normal cells of cervix cancer patients?. Radiat. Prot. Dosim. 2006, 122:282-284.
97. Spring P.M., Arnold S.M., Shajahan S., Brown B., Dey S., Lele S.M., Valentino J., Jones R., Mohiuddin M., Ahmed M.M. Low dose fractionated radiation potentiates the effects of taxotere in nude mice xenografts of squamous cell carcinoma of head and neck. Cell Cycle 2004, 3:479-485.
98. Stojic L., Brun R., Jiricny J. Mismatch repair and DNA damage signalling. DNA Repair (Amst.) 2004, 3:1091-1101.
99. Surtees J.A., Argueso J.L., Alani E. Mismatch repair proteins: key regulators of genetic recombination. Cytogenet. Genome Res. 2004, 107:146-159.
100. Suzuki K., Yamashita S. Low-dose radiation exposure and carcinogenesis. Jpn. J. Clin. Oncol. 2012, 42:563-568.
101. Thomas C., Charrier J., Massart C., Cherel M., Fertil B., Barbet J., Foray N. Low-dose hyper-radiosensitivity of progressive and regressive cells isolated from a rat colon tumour: impact of DNA repair. Int. J. Radiat. Biol. 2008, 84:533-548.
102. Turesson I., Bernefors R., Book M., Flogegard M., Hermansson I., Johansson K.A., Lindh A., Sigurdardottir S., Thunberg U., Nyman J. Normal tissue response to low doses of radiotherapy assessed by molecular markers - a study of skin in patients treated for prostate cancer. Acta Oncol. 2001, 40:941-951.
103. Turesson I., Bernefors R., Book M., Flogegard M., Hermansson I., Johansson K.A., Lindh A., Sigurdardottir S., Thunberg U., Nyman J. Normal tissue response to low doses of radiotherapy assessed by molecular markers - a study of skin in patients treated for prostate cancer. Acta Oncol. 2001, 40:941-951.
104. Turesson I., Nyman J., Qvarnstrom F., Simonsson M., Book M., Hermansson I., Sigurdardottir S., Johansson K.A. A low-dose hypersensitive keratinocyte loss in response to fractionated radiotherapy is associated with growth arrest and apoptosis. Radiother. Oncol. 2010, 94:90-101.
105. Vaganay-Juery S., Muller C., Marangoni E., Abdulkarim B., Deutsch E., Lambin P., Calsou P., Eschwege F., Salles B., Joiner M., Bourhis J. Decreased DNA-PK activity in human cancer cells exhibiting hypersensitivity to low-dose irradiation. Br. J. Cancer 2000, 83:514-518.
106. Valentini V., Massaccesi M., Balducci M., Mantini G., Micciche F., Mattiucci G.C., Dinapoli N., Meduri B., D'Agostino G.R., Salvi G., Nardone L. Low-dose hyperradiosensitivity: is there a place for future investigation in clinical settings?. Int. J. Radiat. Oncol. Biol. Phys. 2010, 76:535-539.
107. Williams J.R., Zhang Y., Zhou H., Gridley D.S., Koch C.J., Slater J.M., Dicello J.F., Little J.B. Sequentially-induced responses define tumour cell radiosensitivity. Int. J. Radiat. Biol. 2011, 87:628-643.
108. Wouters B.G., Skarsgard L.D. The response of a human tumor cell line to low radiation doses: evidence of enhanced sensitivity. Radiat. Res. 1994, 138:S76-S80.
109. Wouters B.G., Skarsgard L.D. Low-dose radiation sensitivity and induced radioresistance to cell killing in HT-29 cells is distinct from the "adaptive response" and cannot be explained by a subpopulation of sensitive cells. Radiat. Res. 1997, 148:435-442.
110. Wouters B.G., Sy A.M., Skarsgard L.D. Low-dose hypersensitivity and increased radioresistance in a panel of human tumor cell lines with different radiosensitivity. Radiat. Res. 1996, 146:399-413.
111. Wrixon A.D. New ICRP recommendations. J. Radiol. Prot. 2008, 28:161-168.
112. Wu H., Chen Q., Zhang Y., Wu G., Meng R., Cheng J. The role of DNA damage repair and Chk2 protein in hyper-radiosensitivity of lung adenocarcinoma A549 cells. J. Huazhong Univ. Sci. Technol. Med. Sci. 2012, 32:750-754.
113. Wykes S.M., Piasentin E., Joiner M.C., Wilson G.D., Marples B. Low-dose hyper-radiosensitivity is not caused by a failure to recognize DNA double-strand breaks. Radiat. Res. 2006, 165:516-524.
114. Wykes S.M., Piasentin E., Joiner M.C., Wilson G.D., Marples B. Low-dose hyper-radiosensitivity is not caused by a failure to recognize DNA double-strand breaks. Radiat. Res. 2006, 165:516-524.
115. Xue L., Yu D., Furusawa Y., Cao J., Okayasu R., Fan S. ATM-dependent hyper-radiosensitivity in mammalian cells irradiated by heavy ions. Int. J. Radiat. Oncol. Biol. Phys. 2009, 75:235-243.
116. Yan T., Seo Y., Kinsella T.J. Differential cellular responses to prolonged LDR-IR in MLH1-proficient and MLH1-deficient colorectal cancer HCT116 cells. Clin. Cancer Res. 2009.
117. Yuan S.S., Chang H.L., Lee E.Y. Ionizing radiation-induced Rad51 nuclear focus formation is cell cycle-regulated and defective in both ATM(-/-) and c-Abl(-/-) cells. Mutat. Res. 2003, 525:85-92.
118. Zhao Y., Cui Y., Han J., Ren J., Wu G., Cheng J. Cell division cycle 25 homolog c effects on low-dose hyper-radiosensitivity and induced radioresistance at elevated dosage in A549 cells. J. Radiat. Res. 2012, 53:686-694.